Industrial, Manufacturing & Heavy Industry Market News

Narcolepsy Therapeutics market examined in new research report

Industrial Market Research

The qualitative research study conducted by Polaris Market Research titled “Global Market Research Report 2017” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global Narcolepsy Therapeutics market. The study provides forecasts for Narcolepsy Therapeutics investments till 2025.

According to the new market research “Global Narcolepsy Therapeutics Market [By Product (Sodium Oxybate, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, and Tricyclic Antidepressants); By Type (Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); and By Regions]: Market size & Forecast, 2018 – 2025", The Narcolepsy Therapeutics market is expected to reach USD 3263.65 Million by 2026 from USD 1348.15 Million in 2017.

Narcolepsy is a therapeutic disorder which is categorized by prodigious daytime sleepiness as well as sudden attacks of sleep. In some cases, this chronic sleep disease can lead to an abrupt loss of muscle tone (cataplexy), leading to loss and weakness of muscle control.

Some of the most common indications of narcolepsy are daytime sleepiness, hallucinations, fragmented sleep & insomnia, and sleep paralysis.

Report: www.polarismarketresearch.com/indu…t-for-free-sample

Major key Player in Global Market: -

Addrenex Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
BIOPROJET
Cephalon, Inc.
Evotec AG
Graymark Healthcare Inc.
Hypnion, Inc.
Jazz Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.

Growing incidence of narcolepsy and increasing overweight populace are the major factors estimated to drive the global narcolepsy therapeutics market growth. For instance, according to the Sleep Science journal 2017 report, it was estimated that around 1 in every 2,000 people across the globe are suffering from narcolepsy disorder.

Moreover, according to the Australian Institute of Health and Welfare, around 63% of the Australian individuals who are aged over 18 years were estimated to be obese or overweight. Additionally, growing research and development activities and growing demands for effective treatment of the disease are another factors expected to boost the market growth.

However, low per capita healthcare spending and lack of awareness majorly in middle income and lower-income economies is estimated to hinder the global narcolepsy therapeutics market during the forecast period.

www.polarismarketresearch.com/indu…/speak-to-analyst

The global Narcolepsy Therapeutics Market is segmented on the basis of product, type, and geography. On the basis of product, the global Narcolepsy Therapeutics Market is segmented into Sodium Oxybate, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, and Tricyclic Antidepressants.

In 2017, Sodium oxybate was estimated to domkiat5e the market segment. The dominance is due to the presence of favorable reimbursement guidelines, the high cost of this drug, and the increasing awareness levels relating to diagnosis & associated treatments of the disease.

On the basis of type, the global Narcolepsy Therapeutics Market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. In 2017, the Narcolepsy with cataplexy segment was estimated to dominate the market growth.

The dominance is attributed to the growing incidence of cataplexy as a major indication in patients.

Read More For Details: www.polarismarketresearch.com/indu…rapeutics-market/

On the basis of region, the global Narcolepsy Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe was estimated to dominate the global Narcolepsy Therapeutics Market.

The dominance is majorly attributed to the well-established healthcare organizations, rising R&D initiatives for the expansion of novel drugs, and high incidence of people suffering from such disorder. However, Asia Pacific is expected to dominate the global Narcolepsy Therapeutics Market during the forecast.

Rising disposable income, increasing investments in biotechnology and pharmaceutical sectors, economic development, supportive government initiatives, and rising awareness among people regarding the appropriate therapies are the factors expected to significantly boost the Narcolepsy Therapeutics Market in the Asia Pacific.

News From

Polaris Market Research & ConsultingPolaris Market Research &...
Category: Market Research Publishers and RetailersCompany about: Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries presen ...
This email address is being protected from spambots. You need JavaScript enabled to view it.